Brief: Evolus Announces EU Approval Of Estyme® Injectable Hyaluronic Acid Gels
31/10/2024 18:04
Oct 31 (Reuters) - Evolus Inc EOLS.O :
* EVOLUS ANNOUNCES EU APPROVAL OF ESTYME® INJECTABLE
HYALURONIC
ACID GELS UNDER NEW MEDICAL DEVICE REGULATION
* ON TRACK FOR U.S. APPROVAL & LAUNCH OF EVOLYSSE INJECTABLE
HA
GELS BEGINNING IN 2025
* BROADER EUROPEAN LAUNCH OF ESTYME® INJECTABLE HYALURONIC
ACID
GELS IS PLANNED FOR H2 OF 2025
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Evolus
See all newsEvolus Inc reports results for the quarter ended June 30 - Earnings Summary
Evolus Q2 revenue rises 21%, lifts 2026 outlook
Brief: Evolus Q2 Product Revenue USD 83.35 Million
Evolus Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Evolus Announces Commercial Launch Of Estyme® Injectable Hyaluronic Acid Gels In Europe